MSA
EXAS

Marino Stram & Associates’s Exact Sciences EXAS Stock Holding History

Marino Stram & Associates’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25
Closed -$2K – 236
2019
Q1 		$2K Buy
25
+10
+67% +$851 ﹤0.01% 525
2018
Q4 		$1K Buy
+15
New +$1.03K ﹤0.01% 553

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marino Stram & Associates's EXAS Position: Q2 2019 in Review

Marino Stram & Associates sold out of Exact Sciences (EXAS) in Q2 2019, closing a stake of 25 shares — an estimated $2K sold.

Marino Stram & Associates first reported a position in EXAS in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q1 2019. 472 funds tracked by Wall St. Rank hold EXAS as of Q2 2019.

  • Marino Stram & Associates reported no remaining Exact Sciences position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 25 Exact Sciences shares in Q2 2019, an estimated $2K.
  • Marino Stram & Associates first reported a position in Exact Sciences in Q4 2018 and held it in 2 quarters.
  • Marino Stram & Associates's Exact Sciences position peaked at $2K in Q1 2019.
  • 472 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.